(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.13%) $79.10
(-0.16%) $1.929
(0.85%) $2 330.60
(0.57%) $26.90
(0.85%) $963.00
(-0.45%) $0.933
(-0.61%) $11.03
(-0.30%) $0.798
(0.06%) $93.51
1.53% $ 13.28
Live Chart Being Loaded With Signals
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe...
Stats | |
---|---|
Tagesvolumen | 56 048.00 |
Durchschnittsvolumen | 99 631.00 |
Marktkapitalisierung | 363.21M |
Nächstes Ertragsdatum | ( $0 ) 2024-06-03 |
Last Dividend | $0.300 ( 2023-11-21 ) |
Next Dividend | $0 ( N/A ) |
P/E | 16.81 |
ATR14 | $0.0210 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Saba Capital Management, L.p. | Buy | 16 573 | Common Stock |
2024-04-26 | Saba Capital Management, L.p. | Buy | 120 304 | Common Stock |
2024-04-25 | Saba Capital Management, L.p. | Buy | 97 574 | Common Stock |
2024-04-24 | Saba Capital Management, L.p. | Buy | 20 529 | Common Stock |
2024-04-23 | Saba Capital Management, L.p. | Buy | 48 203 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 58 transactions |
Buy: 554 423 | Sell: 55 759 |
Volumen Korrelation
Tekla Life Sciences Korrelation
10 Am meisten positiv korreliert | |
---|---|
FPI | 0.888 |
TSN | 0.883 |
ASH | 0.878 |
DHX | 0.878 |
AMRC | 0.874 |
DVN | 0.873 |
CWT | 0.871 |
PDS | 0.868 |
CVX | 0.867 |
EBR-B | 0.864 |
10 Am meisten negativ korreliert | |
---|---|
VCRA | -0.862 |
AMAM | -0.861 |
COR | -0.86 |
SCX | -0.856 |
IOT | -0.853 |
NGL | -0.845 |
FPAC-UN | -0.845 |
MOG-B | -0.842 |
TNK | -0.835 |
TK | -0.831 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Tekla Life Sciences Korrelation - Währung/Rohstoff
Tekla Life Sciences Finanzdaten
Annual | 2023 |
Umsatz: | $23.52M |
Bruttogewinn: | $18.28M (77.71 %) |
EPS: | $0.830 |
FY | 2023 |
Umsatz: | $23.52M |
Bruttogewinn: | $18.28M (77.71 %) |
EPS: | $0.830 |
FY | 2022 |
Umsatz: | $-103.25M |
Bruttogewinn: | $-108.80M (105.37 %) |
EPS: | $-4.07 |
FY | 2021 |
Umsatz: | $65.69M |
Bruttogewinn: | $0.00 (0.00 %) |
EPS: | $2.78 |
Financial Reports:
No articles found.
Tekla Life Sciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.310 (N/A) |
$0.310 (N/A) |
$0.330 (N/A) |
$0.320 (N/A) |
$0.320 (N/A) |
$0.300 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $1.640 | 1996-11-14 |
Last Dividend | $0.300 | 2023-11-21 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-10 | |
Next Payout Date | N/A | |
# dividends | 99 | -- |
Total Paid Out | $43.17 | -- |
Avg. Dividend % Per Year | 5.54% | -- |
Score | 5.04 | -- |
Div. Sustainability Score | 1.232 | |
Div.Growth Potential Score | 1.007 | |
Div. Directional Score | 1.119 | -- |
Year | Amount | Yield |
---|---|---|
1996 | $1.640 | 10.80% |
1997 | $0.740 | 5.38% |
1998 | $0.360 | 2.76% |
1999 | $1.110 | 9.06% |
2000 | $4.16 | 20.50% |
2001 | $3.14 | 14.90% |
2002 | $2.18 | 10.20% |
2003 | $1.240 | 10.10% |
2004 | $1.365 | 8.62% |
2005 | $2.06 | 13.00% |
2006 | $1.240 | 7.90% |
2007 | $1.170 | 8.74% |
2008 | $1.100 | 8.33% |
2009 | $0.420 | 4.59% |
2010 | $0.520 | 5.46% |
2011 | $1.010 | 9.29% |
2012 | $1.160 | 10.00% |
2013 | $1.390 | 9.19% |
2014 | $1.770 | 8.72% |
2015 | $2.80 | 11.20% |
2016 | $2.07 | 8.99% |
2017 | $1.620 | 9.38% |
2018 | $1.620 | 8.18% |
2019 | $1.400 | 9.03% |
2020 | $1.560 | 8.98% |
2021 | $1.690 | 8.71% |
2022 | $1.360 | 7.05% |
2023 | $1.270 | 8.87% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.568 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0556 | 1.200 | 8.15 | 9.78 | [0 - 0.3] |
returnOnEquityTTM | 0.0813 | 1.500 | -0.207 | -0.311 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0000000 | 2.00 | 0.0000000 | 0.0000000 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0000000 | 2.00 | 0.0000000 | 0.0000000 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.867 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.568 | 1.000 | 0.649 | 0.649 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.0978 | 0.800 | -2.68 | -2.14 | [0.5 - 2] |
Total Score | 1.232 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 15.67 | 1.000 | 8.52 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0813 | 2.50 | -0.133 | -0.311 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0000000 | 2.00 | 0.0000000 | 0.0000000 | [0 - 30] |
dividendYielPercentageTTM | 10.17 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0000000 | 2.00 | 0.0000000 | 0.0000000 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0619 | 1.500 | -3.75 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0000000 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | 1.007 |
Tekla Life Sciences
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.